?
學術咨詢服務,正當時...... 期刊天空網是可靠的職稱論文發表專業學術咨詢服務平臺!!!

大類學科: 不限 醫學 生物 物理 化學 農林科學 數學 地學天文 地學 環境科學與生態學 綜合性期刊 管理科學 社會科學 查看全部熱門領域

中科院分區: 不限 1區 2區 3區 4區

期刊收錄: 不限 SCI SCIE

Oncotargets And Therapy

Oncotargets And Therapy
期刊全稱:Oncotargets And Therapy
簡稱:ONCOTARGETS THER
ISSN:1178-6930
ESSN:1178-6930
研究方向:BIOTECHNOLOGY & APPLIED MICROBIOLOGY - ONCOLOGY
投稿咨詢

免費咨詢 2023最新分區

Oncotargets And Therapy英文簡介

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer.

The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype.

Specific topics covered by the journal include:

-Novel therapeutic targets and innovative agents

-Novel therapeutic regimens for improved benefit and/or decreased side effects

-Early stage clinical trials

Further considerations when submitting to OncoTargets and Therapy:

-Studies containing in vivo animal model data will be considered favorably.

-Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines.

-Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples.

-Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Single nucleotide polymorphism (SNP) studies will not be considered.

Oncotargets And Therapy中文簡介

《Oncotargets And Therapy》是一本由DOVE MEDICAL PRESS LTD出版商出版的專業醫學期刊,該刊創刊于2008年,刊期1 issue/year,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 4區,小類學科:生物工程與應用微生物 3區;腫瘤學 4區;在JCR(Journal Citation Reports)分區等級為Q2。該刊發文范圍涵蓋生物工程與應用微生物等領域,旨在及時、準確、全面地報道國內外生物工程與應用微生物工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為4.345,平均審稿速度較慢,6-12周。

中科院分區最新升級版(當前數據版本:2021年12月最新升級版)

大類學科 分區 小類學科 分區 Top期刊 綜述期刊
醫學 4區 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應用微生物 ONCOLOGY 腫瘤學 3區 4區

JCR分區(當前數據版本:2021-2022年最新版)

JCR分區等級 JCR所屬學科 分區 影響因子
Q2 ONCOLOGY Q2 4.345
BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q2

期刊指數

影響因子 h-index Gold OA文章占比 研究類文章占比 OA開放訪問 平均審稿速度
4.345 44 97.03% 84.15% 開放 較慢,6-12周

IF值(影響因子)趨勢圖

?
專家解答 課題、SCI/EI/SSCI怎么寫?

對接專家,全程指導

免費咨詢 >
?
? 7799精品视频